Proton beam imaging for cancer diagnostics moves a step closer
9 March 2010
A new imaging process using a proton beam being developed by
scientists from the Northern Illinois Proton Treatment and Research
Center (NIPTRC) and Northern Illinois University along with their
partners could bring a major medical breakthrough in the delivery of
proton beam therapy for cancer patients.
"By using a proton beam scan instead of an x-ray CT scan to image
a patient prior to treatment, density maps would be more accurate
and the proton beam would stop more precisely on the tumor," said
Research Director and Chief Physicist George Coutrakon, PhD. "This
is advantageous for such tumors located at the brain stem and base
of the skull because precision is absolutely essential in sparing
healthy tissues. This is particularly important for tumors in
Currently, x-ray CT scans are used to develop an image of the
cancer patient and simulate the radiation dose delivered by the
proton beam to the tumor. Although x-ray CT scans have worked well
for many years, they do contain an error margin that researchers
believe could be reduced substantially through the use of proton
beam scanning technology in imaging.
The existing procedure of using x-ray CT scans causes the range
of a proton beam to have a margin of error of about three percent.
By using a proton beam scan instead, the margin of error would be
reduced from approximately three percent to less than one percent
thereby allowing greater dose sparing of healthy tissue.
The discovery comes even as the northern Illinois center is still
"Even though we are not yet operational, there is a great deal of
research activity taking place behind the scenes," said Executive
Director John Lewis. "Our mission is to advance proton therapy to an
even higher level in order to more effectively treat cancer patients
around the world. This will continue and we anticipate more
announcements like this one in the months and years to come."
Nearly 50 years ago, Nobel Prize winner Dr Allan Cormack first
proposed the idea of using protons for scanning instead of x-rays in
a 1963 research paper. Two years ago, NIU and Loma Linda University
in California took Cormack's theory and began work to develop proton
scan technology for proton treatment imaging.
Since then, the two institutes have partnered with Cal State San
Bernardino, the University of California at Santa Cruz (UCSC), and
even the University of Haifa in Israel. NIU's Physics and Computer
Science Departments are making considerable research contributions
to the project as well.
The University of California at Santa Cruz is building a
prototype of the hardware detector needed to collect the data from
the proton beam. This effort is being lead under the direction of
Hartmut Sadrozinski of UCSC and Victor Rykalin from NIU.
This prototype will be ready by the end of this month and used at
Loma Linda to collect the first ever 3-D images of humanlike
phantoms. Researchers will work three to four hours a night during
three or four days each week on the project, and they will use the
same proton beam that treats patients during the daytime. By
September, data collection will be complete and ready to feed into
computers to process.
The software and computer technology required to process the data
presents unique challenges. Currently, it would take hundreds of
hours to construct the 360 degree, 3-D images associated with proton
scans using conventional computers. This needs to be shortened
dramatically to under ten minutes.
In order to develop the software needed to make this technical
leap forward, a partnership has been formed that includes Drs.
Nicholas Karonis and Kirk Duffin from NIU's Computer Science
Department, Dr. Bela Erdelyi from NIU's Physics Department, Dr.
Keith Schubert from Cal State San Bernardino's Computer Science
Department, and Dr. Yair Censor in the Department of Mathematics at
the University of Haifa in Israel.
"We are willing to partner with everyone that wants to advance
the field of proton therapy, whether they are researchers,
physicists, engineers, or doctors," said Lewis. "We believe
establishing these types of collaborative efforts are the key to
innovation and progress."
In fact, NIU is currently in discussions with longtime partner
Argonne National Laboratory's Computer Science Division to use their
cluster of 24 Graphical Processor Units (GPUs) to attain fast image
reconstruction. GPUs are popularly associated with today's
impressive video gaming technology, but their remarkable power is
now needed to help in the fight against cancer.
"We are very grateful to all our partners and the spirit of
cooperation everyone has showed to make this project possible," said
Coutrakon. "I am excited to be involved and look forward to sharing
the final results once we are complete."
While Coutrakon heads up this research project with west coast
universities, radiation physicist Wayne Newhauser, Ph.D. is
performing additional research at the University of Texas' MD
Anderson Cancer Center in Houston. Since the beginning of NIPTRC's
2008 partnership with UT, Newhauser and his colleagues have
published 16 peer-reviewed papers about proton therapy that result
from support provided by NIPTRC in collaboration with NIPTRC's
clinical partner Northwestern Medical Faculty Foundation's
Department of Radiation Oncology. These have appeared in scientific,
engineering, and medical journals. A complete listing is available
on NIPTRC's website at www.niptrc.org.
"The knowledge gained about proton therapy from several of our
applied clinical research projects has proven to be beneficial to
our clinical practice," said Newhauser. "It is abundantly clear to
me that NIPTRC's generous support is key to our collaboration and to
the progression of the education of several of our best students and
post docs. We will continue to strive to create new research and
training opportunities for students, faculty, and staff in order to
fulfill the mission of NIPTRC."
One research project examined the second cancer risk associated
with whole-body exposure to stray neutron radiation from proton
therapy. This risk is especially important to assess in pediatric
cancer cases because they are highly susceptible to second cancers.
Research has already established the overall risk of second cancers
with traditional photon radiation at about 55% and IMRT photon
radiation at 31%. Proton therapy brings this down to around 5% but
questions remained about stray neutron radiation.
"Prior to our study, neutron exposures caused by proton therapy
were not well understood, and previous publications speculated on
the possible dangers of proton therapy, causing confusion as to its
appropriateness for treating children," said Newhauser.
There are two types of proton therapy, passively scattered and
scanned-beam, and Newhauser's research team concluded both
techniques are barely distinguishable in terms of risk specifically
from stray neutron radiation. Passively scattered proton therapy was
estimated at 1.5% and scanned beam proton therapy was estimated at
"Our evidence now shows that the risk is lower following proton
therapy, regardless of the technique used," said Newhauser.
"Nevertheless, there still is risk and it is important to continue
attempts to reduce stray radiation exposure as much as possible.
Together with researchers from NIPTRC, we aim to produce a
high-quality body of evidence to support clinical decision making on
whether a patient receives proton or photon therapy."
Newhauser's graduate students and postdoctoral fellows in medical
physics have garnered numerous awards and recognition for their
research on proton therapy. In addition, as a result of the
partnership, opportunities have been created for NIU, Northwestern
University and UT faculty members to participate in several research